Updated:
BioClinica
Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical...
BioClinica
Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial phase.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Additional offices
Montréal, QC, Canada
Sector focus
Frequently asked questions
How is BioClinica related to Thermo Fisher Scientific?
BioClinica Inc. is the legal entity behind the Clario brand and operates as a part of Thermo Fisher Scientific following an acquisition. It is not a standalone public company or a family office — it sits inside Thermo Fisher’s life-sciences portfolio as the dedicated clinical trial evidence unit. The parent relationship provides balance-sheet support for logistics, device provisioning, and 24/7 global customer support.
Does BioClinica manage third-party capital or invest as a family office?
No. BioClinica does not manage a disclosed external capital pool, and there is no evidence of a family office structure. It is an operating subsidiary of Thermo Fisher Scientific. It deploys its own corporate resources into clinical trial technology and service delivery, not into investment portfolios.
What clinical trial endpoints does BioClinica support?
BioClinica’s platform covers cardiac safety (ECG, blood pressure, arrhythmia monitoring), medical imaging (CT, MRI, endoscopy, and AI-driven redaction), electronic clinical outcome assessments (eCOA) including neuroscience-specific modules, and respiratory function (site-based spirometry, virtual home spirometry, cough monitoring, oscillometry, and DLCO). The firm also markets a wearable-sensor solution under the Precision Motion line for mobility-based digital endpoints.
In how many countries does BioClinica operate?
The firm reports regulatory and operational presence in over 100 countries, with support available in more than 100 languages. Its main offices include Princeton, New Jersey, and Montréal, Quebec.
Who leads BioClinica’s scientific and operational teams?
BioClinica does not publicly name individual principals on its leadership page. The firm’s website references 'key opinion leaders' embedded across its medical imaging and scientific teams, but no single CEO or CIO is attributed to the BioClinica/Clario entity in the available sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: